| 產品名稱 |
Proteus mirabilis Hauser |
| 商品貨號 |
B206075 |
| Strain Designations |
N-3 |
| Application |
Produces an amplifying factor of cortisone induction, AFCI |
| Isolation |
Feces, animal |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol® |
no |
| Type Strain |
no |
| Medium |
ATCC® Medium 3: Nutrient agar or nutrient broth
|
| Growth Conditions |
Temperature: 37.0°C |
| Name of Depositor |
Chugai Pharm. Co., Ltd. |
| U.S. Patent Number |
|
| Chain of Custody |
ATCC <<--Chugai Pharm. Co., Ltd.<<--Dr. Tomino |
| References |
Katunuma N. Amplifying factor of cortisone induction and process of the production thereof. US Patent 3,928,568 dated Dec 23 1975
albino rat feces
|
